RaQualia Pharma gets substance patent for ghrelin receptor agonist(serine derivative) in Japan
Friday, October 07, 2016
RaQualia Pharma Inc Says it received substance patent for ghrelin receptor agonist(serine derivative) in Japan. Says the substance is used for improvement of anorexia and suppression of body weight reduction.
Source : reuters.com
